Charles Gayer Net Worth & Insider Trades

Charles Gayer - Chief Commercial Officer, Biocryst Pharmaceuticals Inc

As of December 21, 2022

What is Charles Gayer's Net Worth?

The current estimated net worth of Biocryst Pharmaceuticals Inc's Chief Commercial Officer, Charles Gayer, is estimated to be about $1.91M . Charles Gayer owns about 211,610 units of Biocryst Pharmaceuticals Inc common stock. In the last 2 years at Biocryst Pharmaceuticals Inc, Charles Gayer has sold an estimated value of $66.49K worth.

What is Charles Gayer's Past Insider Trading?

Charles Gayer's largest sale order was 6,100 units , worth over $66.49K on December 19, 2022. In total, Charles Gayer has made about 4 transactions over 2 years of their time at Biocryst Pharmaceuticals Inc. Charles Gayer usually trades in December, with the busiest year in 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Charles Gayer

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Charles Gayer's' Mailing Address?

  • Mailing address is 4505 Emperor Blvd. Suite 200 Durham NC 27703 NC

What are Biocryst Pharmaceuticals Inc's Past Insider Trades?

Biocryst Pharmaceuticals Inc's most recent insider trade came on June 15, 2023 by MacHelle Sanders who sold 4,000 units worth $31.92K . In the last 20 years, insiders at Biocryst Pharmaceuticals Inc have sold an estimated value of $87.35M and bought an estimated value of $35.52M worth of shares. Insider trading is most common in May, with the busiest year in 2015. The most active traders at the company are Thomas Staab II, Senior Vice President and CFO,  Jon Stonehouse, President & CEO,  and William Sheridan, Chief Medical Officer .

BIOCRYST PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...